These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Converging goals of treatment of inflammatory bowel disease from clinical trials and practice. Levesque BG; Sandborn WJ; Ruel J; Feagan BG; Sands BE; Colombel JF Gastroenterology; 2015 Jan; 148(1):37-51.e1. PubMed ID: 25127678 [TBL] [Abstract][Full Text] [Related]
3. Patient-Reported Outcome Measures for Use in Clinical Trials and Clinical Practice in Inflammatory Bowel Diseases: A Systematic Review. de Jong MJ; Huibregtse R; Masclee AAM; Jonkers DMAE; Pierik MJ Clin Gastroenterol Hepatol; 2018 May; 16(5):648-663.e3. PubMed ID: 29074448 [TBL] [Abstract][Full Text] [Related]
4. The IBD Disability Index should become a Major Secondary Endpoint in Clinical Practice and in Clinical Trials. Peyrin-Biroulet L; Gower-Rousseau C J Crohns Colitis; 2016 Dec; 10(12):1375-1377. PubMed ID: 27664272 [No Abstract] [Full Text] [Related]
5. [Evolving Therapeutic Strategies in the Inflammatory Bowel Disease]. Na SY; Moon W Korean J Gastroenterol; 2018 Feb; 71(2):61-68. PubMed ID: 29471602 [TBL] [Abstract][Full Text] [Related]
6. Cross-cultural translation and validation of the IBD-control questionnaire in The Netherlands: a patient-reported outcome measure in inflammatory bowel disease. de Jong ME; Taal E; Thomas PWA; Römkens TEH; Jansen JM; West RL; Slotman E; Hoentjen F; Russel MGVM Scand J Gastroenterol; 2021 Feb; 56(2):155-161. PubMed ID: 33300822 [TBL] [Abstract][Full Text] [Related]
7. Standardisation of Study Protocols - Pros and Cons. D'Haens G J Crohns Colitis; 2016 Sep; 10 Suppl 2():S553-9. PubMed ID: 27604980 [TBL] [Abstract][Full Text] [Related]
8. Correlation of health-related quality of life in children with inflammatory bowel disease, their parents, and physician as measured by a visual analog scale. Teitelbaum JE; Rajaraman RR; Jaeger J; Para S; Rakitt T J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):594-7. PubMed ID: 23752079 [TBL] [Abstract][Full Text] [Related]
9. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy. Nørgård BM Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578 [TBL] [Abstract][Full Text] [Related]
10. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. ; ; Health Qual Life Outcomes; 2006 Oct; 4():79. PubMed ID: 17034633 [TBL] [Abstract][Full Text] [Related]
11. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease). Ruther U; Nunnensiek C; Muller HA; Bader H; May U; Jipp P Hepatogastroenterology; 1998; 45(21):691-9. PubMed ID: 9684118 [TBL] [Abstract][Full Text] [Related]
13. A national survey on the patterns of treatment of inflammatory bowel disease in Canada. Hilsden RJ; Verhoef MJ; Best A; Pocobelli G BMC Gastroenterol; 2003 Jun; 3():10. PubMed ID: 12791168 [TBL] [Abstract][Full Text] [Related]
14. Evolution of Clinical Trials in Inflammatory Bowel Diseases. Singh S Curr Gastroenterol Rep; 2018 Aug; 20(9):41. PubMed ID: 30078058 [TBL] [Abstract][Full Text] [Related]
15. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus. Bourreille A; Ignjatovic A; Aabakken L; Loftus EV; Eliakim R; Pennazio M; Bouhnik Y; Seidman E; Keuchel M; Albert JG; Ardizzone S; Bar-Meir S; Bisschops R; Despott EJ; Fortun PF; Heuschkel R; Kammermeier J; Leighton JA; Mantzaris GJ; Moussata D; Lo S; Paulsen V; Panés J; Radford-Smith G; Reinisch W; Rondonotti E; Sanders DS; Swoger JM; Yamamoto H; Travis S; Colombel JF; Van Gossum A; Endoscopy; 2009 Jul; 41(7):618-37. PubMed ID: 19588292 [TBL] [Abstract][Full Text] [Related]